tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

URGN Stock Latest News

URGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Pre-EarningsURGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
2h ago
URGN
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
9d ago
NVS
ABEO
Urogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
PremiumRatings
Urogen Pharma’s UGN-102: Promising Efficacy and Market Potential Justify Buy Rating
12d ago
URGN
UroGen Pharma announces patient-reported outcomes on UGN-102
PremiumThe Fly
UroGen Pharma announces patient-reported outcomes on UGN-102
13d ago
URGN
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
PremiumThe Fly
UroGen Pharma announces long-term follow up data from OPTIMA II Phase 2b study
13d ago
URGN
UroGen Pharma reports long-term follow-up study with JELMYTO
PremiumThe FlyUroGen Pharma reports long-term follow-up study with JELMYTO
13d ago
URGN
UroGen Pharma announces results from Phase 1 study of UGN-301
Premium
The Fly
UroGen Pharma announces results from Phase 1 study of UGN-301
13d ago
URGN
UroGen Pharma announces updated 18-month DOR data from Phase 3 ENVISION trial
Premium
The Fly
UroGen Pharma announces updated 18-month DOR data from Phase 3 ENVISION trial
13d ago
URGN
UroGen Pharma initiated with an Outperform at Scotiabank
PremiumThe Fly
UroGen Pharma initiated with an Outperform at Scotiabank
24d ago
URGN
UroGen Pharma’s Earnings Call Highlights Progress and Challenges
PremiumCompany Announcements
UroGen Pharma’s Earnings Call Highlights Progress and Challenges
2M ago
URGN
UroGen Pharma price target lowered to $55 from $64 at H.C. Wainwright
PremiumThe Fly
UroGen Pharma price target lowered to $55 from $64 at H.C. Wainwright
2M ago
URGN
UroGen Pharma Reports Strong Pipeline Progress and Revenue Growth
PremiumCompany Announcements
UroGen Pharma Reports Strong Pipeline Progress and Revenue Growth
2M ago
URGN
UroGen Pharma reports Q4 EPS (80c), consensus (72c)
PremiumThe FlyUroGen Pharma reports Q4 EPS (80c), consensus (72c)
2M ago
URGN
UroGen Pharma sees FY25 operating expenses $215M-$225M
Premium
The Fly
UroGen Pharma sees FY25 operating expenses $215M-$225M
2M ago
URGN
Options Volatility and Implied Earnings Moves Today, March 10, 2025
Premium
Market News
Options Volatility and Implied Earnings Moves Today, March 10, 2025
2M ago
FNV
MTN
Urogen Pharma (URGN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Urogen Pharma (URGN) Q4 Earnings Cheat Sheet
2M ago
URGN
Urogen Pharma’s Strategic Acquisitions and Pipeline Developments Drive Buy Rating with $64 Price Target
PremiumRatings
Urogen Pharma’s Strategic Acquisitions and Pipeline Developments Drive Buy Rating with $64 Price Target
2M ago
URGN
UroGen Pharma acquires ICVB-1042 from IconOVir Bio for $19M in cash, shares
PremiumThe Fly
UroGen Pharma acquires ICVB-1042 from IconOVir Bio for $19M in cash, shares
3M ago
URGN
UroGen Pharma transferred with Buy rating at Ladenburg
PremiumThe Fly
UroGen Pharma transferred with Buy rating at Ladenburg
3M ago
URGN
UroGen announces results from subgroup analyses of ENVISION trial
PremiumThe FlyUroGen announces results from subgroup analyses of ENVISION trial
3M ago
URGN
UroGen Pharma announces results from long-term Jelmyto follow-up study
Premium
The Fly
UroGen Pharma announces results from long-term Jelmyto follow-up study
3M ago
URGN
UroGen Pharma reports ENVISION results to be published in The Journal of Urology
Premium
The Fly
UroGen Pharma reports ENVISION results to be published in The Journal of Urology
4M ago
URGN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >